CompaniesByCap
TCRT
Alaunos Therapeutics Inc. (TCRT)
NASDAQ · Healthcare

Alaunos Therapeutics Inc. Cash Flow 2011–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Cash Flow-2.9M-5.0M-30.1M-29.2M-61.5M-57.0M-40.9M-49.5M-54.7M-58.3M-59.5M-78.8M-38.8M-19.7M-12.3M
Depreciation & Amort.290,000738,000658,000268,000188,000330,000
Investing Activities
Capital Expenditure98,0000197,000216,0003.3M9.8M284,000459,000737,000551,000132,0001.6M1.2M186,00011,000
Free Cash Flow-3.0M-5.0M-30.3M-29.4M-64.8M-66.8M-41.1M-49.9M-55.4M-58.9M-59.6M-80.4M-40.0M-19.9M-12.3M
Financing Activities
Dividends Paid
Stock Buybacks045,0000653,0001.6M02,000498,000546,000274,0001.7M380,000

Alaunos Therapeutics Inc. Cash Flow — FAQ

Alaunos Therapeutics Inc. (TCRT) cash flow over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TCRT's cash flow history?

The chart and table above show Alaunos Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.